Text Size
772 studies found for:    Open Studies | "Blood Coagulation Disorders"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.
Conditions: Blood Coagulation Disorders;   Hemorrhage
Intervention: Drug: Human fibrinogen concentrate
2 Unknown † An Observational Study of Early Coagulopathy, or Clotting Disorder, in Injured Patients
Condition: Trauma-Induced Coagulopathy
Intervention:
3 Recruiting Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
Conditions: Severe Sepsis;   Coagulopathy
Interventions: Drug: ART-123;   Drug: Placebo
4 Recruiting Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury
Conditions: Traumatic Brain Injury;   Coagulation Disorder
Intervention:
5 Recruiting Study Using Plasma for Patients Requiring Emergency Surgery
Conditions: Hemorrhagic Shock;   Blood Coagulation Disorders;   Blood Products;   Trauma;   Ruptured AAA
Intervention: Drug: Human Plasma
6 Recruiting Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma
Condition: Acute Coagulopathy
Interventions: Biological: Blood product transfusion based on conventional coagulation tests.;   Biological: Blood product transfusion based on rapid thrombelastography (r-TEG) results.
7 Recruiting Fibrinogen as an Alternative to FFP in Aortic Surgery.
Condition: Coagulopathy in Patients Having Thoraco-Abdominal Aneurysm Repair
Interventions: Biological: Fibrinogen concentrate;   Biological: Fresh Frozen Plasma
8 Unknown † Evaluation of Menses in Congenital Bleeding Disorders
Conditions: Von Willebrand Disease;   Congenital Coagulation Factors Deficiency;   Haemophilia Carriers
Intervention:
9 Recruiting The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass
Condition: Blood Coagulation Disorders
Intervention: Device: method of returning residual CPB blood ( Hemobag®)
10 Unknown † The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots
Condition: Blood Coagulation Disorders
Interventions: Device: Levonorgestrel-containing IUD (Mirena®);   Device: Copper-containing IUD (Paraguard®)
11 Recruiting The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Conditions: Patients Undergoing Routine Health Care;   Heart Diseases;   Inflammatory Bowel Diseases;   Autoimmune Disease;   Inflammatory Disease;   Blood Coagulation Disorders;   Hepatitis C;   Non-Metastatic Neoplasm
Intervention:
12 Recruiting A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Conditions: Primary Myelofibrosis;   Thrombocythemia, Essential;   Thrombocytosis;   Myeloproliferative Disorders;   Bone Marrow Diseases;   Hematologic Diseases;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hemorrhagic Disorders
Interventions: Drug: LDE225;   Drug: INC424
13 Unknown † Clinical and Economic Implications of Genetic Testing for Warfarin Management
Condition: Blood Coagulation Disorders
Intervention: Drug: Warfarin
14 Unknown † "Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
Conditions: Myocardial Ischemia;   Blood Coagulation Disorders;   Coronary Artery Disease;   Heart Valve Diseases
Intervention: Drug: Recombinant Activated Factor VII
15 Recruiting European Transfusion Practice and Outcome Study
Conditions: Surgery;   Erythrocyte Transfusion;   Habits;   Anemia;   Blood Coagulation Disorders
Intervention:
16 Unknown † Education Program for Patients Receiving Oral Anticoagulation
Conditions: Cardiovascular Disease;   Venous Thromboses;   Atrial Fibrillation;   Blood Coagulation Disorders, Inherited
Intervention: Behavioral: Educational program
17 Recruiting A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: NNC 0129-0000-1003
18 Recruiting Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: NNC-0156-0000-0009
19 Recruiting Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: NNC 0129-0000-1003
20 Recruiting Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
Conditions: Congenital Bleeding Disorder;   Haemophilia B
Intervention: Drug: NNC-0156-0000-0009
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years